RE:RE:Excellent news! Out first official exposure to ASCO world There are rules for abstracts and presentation. It's not as one wants!
The upcoming presentation should have the same type of data than the Ph. 1b data:
https://www.sciencedirect.com/science/article/pii/S2666168322005900
By the way, late abstract deadline for April 29 congress is Feb. 13.
For the June 2-6 ASCO conference, that Feb. 12:
June 2-6, 2023 • McCormick Place • Chicago, IL & Online
Abstract Submission
Hero Text
The 2023 Annual Meeting is now accepting abstract submissions until February 14. View the Call for Abstracts booklet for detailed information on submitting an abstract including submission categories, guidelines, and policies.
For our Feb. ASCO one, that Dec. 13:
Body
The ASCO late-breaking data policy allows for the submission of late-breaking data only for:
- Randomized phase II and III trials for which no preliminary data are available at the time of the abstract submission deadline (October 11, 2022);
OR
- Original research studies that highlight novel and high-impact research with practice-changing implications
The initial abstract must be submitted by the October 11, 2022 deadline in a placeholder (shell) abstract submission. During submission, you will be required to enter all authors, the Background and Methods sections, and provide the primary clinical endpoint for analysis, type of analysis, date of planned analysis, and planned statistical methods.
The policy is not a mechanism to allow for updated data to be submitted later when preliminary data are available by the abstract submission deadline. Additionally, late-breaking submissions cannot be a revision of an abstract submitted during the regular submission process.
Guidelines for Consideration
Body
For an abstract to be considered for late-breaking data submissions status, the first author must:
- Submit an abstract, completing all steps in the submitter with the exception of the Results and Conclusions sections, by the abstract submission deadline (October 11, 2022)
- Adhere to the confidentiality policy
- Describe the type of data that will be submitted by the late-breaking data submission deadline, indicating the primary clinical endpoint for analysis, planned statistical plan for analysis, and date of planned analysis. (For example, “Survival data for the two treatment arms will be compared using a log-rank test.”) In general, ASCO discourages reporting of interim analysis results, unless approved by the study’s Data and Safety Monitoring Committee.
The final, updated late-breaking data should be submitted by December 13, 2022, at 12:00 PM (Noon) EST -- the late-breaking submission deadline. If an updated abstract with data and analyses is not submitted, ASCO will follow up with the authors directly to determine appropriate next steps.